• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管医学中的秋水仙碱疗法:文献综述

Colchicine therapy in cardiovascular medicine: A literature review.

作者信息

Trube Jennifer, Sabina Michael, Khanani Aqeel, Hernandez Kayla, Khan Zoya, Bizanti Anas

机构信息

Lakeland Regional Health Medical Center, Lakeland, FL, USA.

出版信息

Am Heart J Plus. 2025 Mar 8;52:100525. doi: 10.1016/j.ahjo.2025.100525. eCollection 2025 Apr.

DOI:10.1016/j.ahjo.2025.100525
PMID:40124716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11929935/
Abstract

INTRODUCTION

Inflammation is a key risk factor in cardiovascular diseases, such as atherosclerosis, and has been linked to increased mortality following myocardial infarction. While inflammation promotes tissue repair, sustained inflammation can drive adverse cardiac remodeling, fibrosis, and impaired contractility, resulting in poorer outcomes. This maladaptive remodeling, compounded by oxidative stress, also predisposes patients to cardiovascular diseases. Colchicine has shown anti-inflammatory benefits in cardiovascular disease, but its role in individual diseases remains unclear. This literature review seeks to understand and evaluate the clinical trials evaluating colchicine in cardiovascular treatment.

METHODS

A literature search identified randomized controlled trials (RCTs) evaluating colchicine in cardiovascular disease including coronary artery disease, post-myocardial infarction treatment, atrial fibrillation, heart failure, and stroke.

CONCLUSIONS

Colchicine has been studied across many cardiovascular conditions including atrial fibrillation (AF), coronary artery disease (CAD), post-myocardial infarction treatment, heart failure (HF) and stroke; however, evidence of its clinical effectiveness remains mixed. While colchicine has shown prfomise in reducing recurrent cardiovascular events in stable CAD, its impact in postoperative AF prevention, acute coronary syndrome (ACS), HF, and stroke prevention is limited.

摘要

引言

炎症是心血管疾病(如动脉粥样硬化)的关键危险因素,且与心肌梗死后死亡率增加有关。虽然炎症促进组织修复,但持续的炎症会导致不良的心脏重塑、纤维化和收缩功能受损,从而导致更差的预后。这种由氧化应激加剧的适应性不良重塑也使患者易患心血管疾病。秋水仙碱已显示出对心血管疾病具有抗炎作用,但其在个别疾病中的作用仍不明确。这篇文献综述旨在了解和评估评价秋水仙碱在心血管治疗中的临床试验。

方法

文献检索确定了评估秋水仙碱在心血管疾病(包括冠状动脉疾病、心肌梗死后治疗、心房颤动、心力衰竭和中风)中的随机对照试验(RCT)。

结论

秋水仙碱已在许多心血管疾病中进行了研究,包括心房颤动(AF)、冠状动脉疾病(CAD)、心肌梗死后治疗、心力衰竭(HF)和中风;然而,其临床有效性的证据仍然不一。虽然秋水仙碱在降低稳定型CAD的心血管事件复发方面显示出前景,但其在预防术后AF、急性冠状动脉综合征(ACS)、HF和中风方面的影响有限。

相似文献

1
Colchicine therapy in cardiovascular medicine: A literature review.心血管医学中的秋水仙碱疗法:文献综述
Am Heart J Plus. 2025 Mar 8;52:100525. doi: 10.1016/j.ahjo.2025.100525. eCollection 2025 Apr.
2
Colchicine for the primary prevention of cardiovascular events.秋水仙碱用于心血管事件的一级预防。
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD015003. doi: 10.1002/14651858.CD015003.pub2.
3
Colchicine for cardiovascular medicine: a systematic review and meta-analysis.秋水仙碱在心血管医学中的应用:系统评价和荟萃分析。
Future Cardiol. 2022 Aug;18(8):647-659. doi: 10.2217/fca-2020-0206. Epub 2022 Jul 5.
4
A meta-analysis evaluating efficacy and safety of colchicine for prevention of major cardiovascular events in patients with coronary artery disease.一项评估秋水仙碱预防冠心病患者主要心血管事件的疗效和安全性的荟萃分析。
Clin Res Cardiol. 2023 Nov;112(11):1487-1505. doi: 10.1007/s00392-023-02254-9. Epub 2023 Jul 28.
5
The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trials.秋水仙碱对心肌梗死的影响:一项更新的随机对照试验的系统评价和荟萃分析。
Curr Probl Cardiol. 2025 Jan;50(1):102878. doi: 10.1016/j.cpcardiol.2024.102878. Epub 2024 Oct 10.
6
Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.秋水仙碱可能成为冠状动脉疾病的新基石治疗方法:一项随机对照试验的荟萃分析。
Clin Rheumatol. 2022 Jun;41(6):1873-1887. doi: 10.1007/s10067-022-06050-0. Epub 2022 Feb 9.
7
Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials.秋水仙碱用于心脏病治疗:随机对照试验的系统评价与荟萃分析
BMC Cardiovasc Disord. 2015 Aug 29;15:96. doi: 10.1186/s12872-015-0068-3.
8
Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.秋水仙碱在冠心病患者中的疗效与安全性:一项随机对照试验的系统评价和荟萃分析
Br J Clin Pharmacol. 2022 Feb;88(4):1520-1528. doi: 10.1111/bcp.15041. Epub 2021 Sep 9.
9
Colchicine in coronary artery disease.秋水仙碱治疗冠状动脉疾病。
Postgrad Med J. 2022 Sep;98(1163):718-721. doi: 10.1136/postgradmedj-2020-139611. Epub 2021 Mar 29.
10
Colchicine efficacy and safety for the treatment of cardiovascular diseases.秋水仙碱治疗心血管疾病的疗效和安全性。
Intern Emerg Med. 2021 Sep;16(6):1691-1700. doi: 10.1007/s11739-021-02654-7. Epub 2021 Mar 11.

引用本文的文献

1
Current anti-inflammatory strategies for treatment of heart failure: From innate to adaptive immunity.当前治疗心力衰竭的抗炎策略:从固有免疫到适应性免疫。
Pharmacol Res. 2025 Jun;216:107761. doi: 10.1016/j.phrs.2025.107761. Epub 2025 May 8.

本文引用的文献

1
Colchicine in Acute Myocardial Infarction.秋水仙碱与急性心肌梗死
N Engl J Med. 2025 Feb 13;392(7):633-642. doi: 10.1056/NEJMoa2405922. Epub 2024 Nov 17.
2
The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trials.秋水仙碱对心肌梗死的影响:一项更新的随机对照试验的系统评价和荟萃分析。
Curr Probl Cardiol. 2025 Jan;50(1):102878. doi: 10.1016/j.cpcardiol.2024.102878. Epub 2024 Oct 10.
3
Colchicine in acutely decompensated heart failure: the COLICA trial.秋水仙碱治疗急性失代偿性心力衰竭:COLICA试验
Eur Heart J. 2024 Aug 30;45(45):4826-36. doi: 10.1093/eurheartj/ehae538.
4
Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.光学相干断层成像术评价秋水仙碱对急性冠状动脉综合征患者冠脉斑块稳定性的影响:COLOCT 随机临床试验。
Circulation. 2024 Sep 24;150(13):981-993. doi: 10.1161/CIRCULATIONAHA.124.069808. Epub 2024 Aug 21.
5
Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial.秋水仙碱治疗急性缺血性卒中和短暂性脑缺血发作患者(CHANCE-3)的多中心、双盲、随机、安慰剂对照试验
BMJ. 2024 Jun 26;385:e079061. doi: 10.1136/bmj-2023-079061.
6
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.长期使用秋水仙碱预防非心源性卒中的血管复发性事件(CONVINCE):一项随机对照试验。
Lancet. 2024 Jul 13;404(10448):125-133. doi: 10.1016/S0140-6736(24)00968-1. Epub 2024 Jun 7.
7
Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones.了解缺血性脑卒中的病理生理学:当前治疗方法的基础和新方法的机会。
Biomolecules. 2024 Mar 4;14(3):305. doi: 10.3390/biom14030305.
8
Colchicine to Prevent Atrial Fibrillation Recurrence After Catheter Ablation: A Randomized, Placebo-Controlled Trial.秋水仙碱预防导管消融后心房颤动复发的随机、安慰剂对照试验。
Circ Arrhythm Electrophysiol. 2024 Jan;17(1):e01238. doi: 10.1161/CIRCEP.123.012387. Epub 2023 Dec 21.
9
Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial.大胸外科手术患者中,秋水仙碱对非心脏手术后围手术期心房颤动和心肌损伤的影响(COP-AF):一项国际随机试验。
Lancet. 2023 Nov 4;402(10413):1627-1635. doi: 10.1016/S0140-6736(23)01689-6. Epub 2023 Aug 25.
10
Inflammation in acute myocardial infarction: the good, the bad and the ugly.急性心肌梗死中的炎症:有好有坏有丑恶。
Eur Heart J. 2024 Jan 7;45(2):89-103. doi: 10.1093/eurheartj/ehad486.